Skip to main content
Log in

Glutathione S-transferase gene polymorphisms and susceptibility to chronic myeloid leukemia

  • Research Article
  • Published:
Tumor Biology

Abstract

Glutathione S-transferase (GST), a phase II metabolizing enzyme, plays an important role in the cellar defense system, and its activity may modulate leukemia risk. A large body of evidence has shown the possible relevance of functional polymorphisms of the genes that encode GSTs μ, π, and θ (GSTM1, GSTP1, and GST1, respectively) to the genetic susceptibility of chronic myeloid leukemia (CML). Because of the lack of available conclusive data, we performed a meta-analysis of all relevant available studies to derive a more precise estimation of the relationship. A comprehensive literature search of PubMed and Web of Knowledge electronic databases was conducted to collect relevant studies until December 20, 2013, and the extracted data were statistically analyzed using Review Manager version 5.2. Finally, 16 eligible studies were identified in the literature. The GSTT1 null genotype was associated with an increased risk of CML, as were the double null GSTT1 and GSTM1 genotypes. These findings suggest that heritable GST status influences the risk of developing CML and that more attention should be paid to carriers of these susceptibility genes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Karkucak M et al. Investigation of GSTP1 (Ile105Val) gene polymorphism in chronic myeloid leukaemia patients. Int J Hum Genet. 2012;12(3):145–9.

    CAS  Google Scholar 

  2. Nowicki MO et al. BCR/ABL oncogenic kinase promotes unfaithful repair of the reactive oxygen species-dependent DNA double-strand breaks. Blood. 2004;104(12):3746–53.

    Article  CAS  PubMed  Google Scholar 

  3. Ishikawa K, Ishii H, Saito T. DNA damage-dependent cell cycle checkpoints and genomic stability. DNA Cell Biol. 2006;25(7):406–11.

    Article  CAS  PubMed  Google Scholar 

  4. Kennedy RD, D’Andrea AD. DNA repair pathways in clinical practice: lessons from pediatric cancer susceptibility syndromes. J Clin Oncol. 2006;24(23):3799–808.

    Article  CAS  PubMed  Google Scholar 

  5. Voso MT et al. Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes. Ann Oncol. 2007;18(9):1523–8.

    Article  CAS  PubMed  Google Scholar 

  6. Taspinar M et al. CYP1A1, GST gene polymorphisms and risk of chronic myeloid leukemia. Swiss Med Wkly. 2008;138(1–2):12–7.

    CAS  PubMed  Google Scholar 

  7. Bhatla D et al. DNA repair polymorphisms and outcome of chemotherapy for acute myelogenous leukemia: a report from the Children’s Oncology Group. Leukemia. 2008;22(2):265–72.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol. 1995;30(6):445–600.

    Article  CAS  PubMed  Google Scholar 

  9. Mannervik B et al. Nomenclature for mammalian soluble glutathione transferases. Methods Enzymol. 2005;401:1–8.

    Article  CAS  PubMed  Google Scholar 

  10. Alves S et al. The GSTM1 and GSTT1 genetic polymorphisms and susceptibility to acute lymphoblastic leukemia in children from north Portugal. Leukemia. 2002;16(8):1565–7.

    Article  CAS  PubMed  Google Scholar 

  11. Strange RC et al. Glutathione-S-transferase family of enzymes. Mutat Res. 2001;482(1–2):21–6.

    Article  CAS  PubMed  Google Scholar 

  12. Sailaja K et al. Association of the GSTP1 gene (Ile105Val) polymorphism with chronic myeloid leukemia. Asian Pac J Cancer Prev. 2010;11(2):461–4.

    PubMed  Google Scholar 

  13. Dunna NR et al. Association of GSTP1 gene (I105V) polymorphism with acute leukaemia. J Genet. 2012;91(1):e60–3.

    PubMed  Google Scholar 

  14. Watson MA et al. Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis. 1998;19(2):275–80.

    Article  CAS  PubMed  Google Scholar 

  15. Harries LW et al. Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis. 1997;18(4):641–4.

    Article  CAS  PubMed  Google Scholar 

  16. Bajpai P, Tripathi AK, Agrawal D. Increased frequencies of glutathione-S-transferase (GSTM1 and GSTT1) null genotypes in Indian patients with chronic myeloid leukemia. Leuk Res. 2007;31(10):1359–63.

    Article  CAS  PubMed  Google Scholar 

  17. Bhat G et al. Polymorphic variation in glutathione-S-transferase genes and risk of chronic myeloid leukaemia in the Kashmiri population. Asian Pac J Cancer Prev. 2012;13(1):69–73.

    Article  PubMed  Google Scholar 

  18. Chen HC et al. Genetic polymorphisms of metabolic enzymes CYP1A1, CYP2D6, GSTM1 and GSTT1 and leukemia susceptibility. Eur J Cancer Prev. 2008;17(3):251–8.

    Article  CAS  PubMed  Google Scholar 

  19. Hishida A et al. GSTT1 and GSTM1 deletions, NQO1 C609T polymorphism and risk of chronic myelogenous leukemia in Japanese. Asian Pac J Cancer Prev. 2005;6(3):251–5.

    PubMed  Google Scholar 

  20. Loffler H et al. Reduced risk for chronic myelogenous leukemia in individuals with the cytochrome P-450 gene polymorphism CYP1A1*2A. Blood. 2001;98(13):3874–5.

    Article  CAS  Google Scholar 

  21. Lordelo GS et al. Association between methylene tetrahydrofolate reductase and glutathione S-transferase M1 gene polymorphisms and chronic myeloid leukemia in a Brazilian population. Genet Mol Res. 2012;11(2):1013–26.

    Article  CAS  PubMed  Google Scholar 

  22. Lourenco GJ et al. Polymorphisms of glutathione S-transferase mu1 (GSTM1) and theta 1 (GSTT1) genes in chronic myeloid leukaemia. Eur J Haematol. 2005;75(6):530–1.

    Article  CAS  PubMed  Google Scholar 

  23. Mondal BC et al. Glutathione S-transferase M1 and T1 null genotype frequency in chronic myeloid leukaemia. Eur J Cancer Prev. 2005;14(3):281–4.

    Article  CAS  PubMed  Google Scholar 

  24. Ovsepian VA, Vinogradova E, Sherstneva ES. Cytochrome P4501A1, glutathione S-transferase M1 and T1 gene polymorphisms in chronic myeloid leukemia. Genetika. 2010;46(10):1360–2.

    CAS  PubMed  Google Scholar 

  25. Ozten N, Sunguroglu A, Bosland MC. Variations in glutathione-S-transferase genes influence risk of chronic myeloid leukemia. Hematol Oncol. 2012;30(3):150–5.

    Article  CAS  PubMed  Google Scholar 

  26. Souza CL et al. Polymorphisms in the glutathione S-transferase theta and mu genes and susceptibility to myeloid leukemia in Brazilian patients. Genet Mol Biol. 2008;31(1):39–41.

    Article  CAS  Google Scholar 

  27. Lemos MC et al. Genetic polymorphism of CYP2D6, GSTM1 and NAT2 and susceptibility to haematological neoplasias. Carcinogenesis. 1999;20(7):1225–9.

    Article  CAS  PubMed  Google Scholar 

  28. Ouerhani S et al. Influence of genetic polymorphisms of xenobiotic metabolizing enzymes on the risk of developing leukemia in a Tunisian population. Bull Cancer. 2011;98(12):95–106.

    PubMed  Google Scholar 

  29. Lopez-Lopez, E., et al., A systematic review and meta-analysis of MTHFR polymorphisms in methotrexate toxicity prediction in pediatric acute lymphoblastic leukemia. Pharmacogenomics J, 2012.

  30. Gurion R et al. Has the time for first-line treatment with second generation tyrosine kinase inhibitors in patients with chronic myelogenous leukemia already come? Systematic review and meta-analysis. Haematologica. 2013;98(1):95–102.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  31. Egger M et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  32. Kawajiri K et al. The CYP1A1 gene and cancer susceptibility. Crit Rev Oncol Hematol. 1993;14(1):77–87.

    Article  CAS  PubMed  Google Scholar 

  33. Tan W et al. Impact of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferases M1, T1, and P1 on susceptibility to esophageal cancer among high-risk individuals in China. Cancer Epidemiol Biomarkers Prev. 2000;9(6):551–6.

    CAS  PubMed  Google Scholar 

  34. Zintzaras E. Glutathione S-transferase M1 and T1 genes and susceptibility to chronic myeloid leukemia: a meta-analysis. Genet Test Mol Biomarkers. 2009;13(6):791–7.

    Article  CAS  PubMed  Google Scholar 

  35. Das P, Shaik AP, Bammidi VK. Meta-analysis study of glutathione-S-transferases (GSTM1, GSTP1, and GSTT1) gene polymorphisms and risk of acute myeloid leukemia. Leuk Lymphoma. 2009;50(8):1345–51.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by the National Natural Science Foundation of China (No. 81071765; 81372379) and the Fundamental Research Funds for the Central Universities (No. 08143047) of China.

Conflicts of interest

None

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Ya-lin Dong or Jun Lu.

Additional information

H.-r. He and X.-x. Zhang contributed equally to this manuscript

Rights and permissions

Reprints and permissions

About this article

Cite this article

He, Hr., Zhang, Xx., Sun, Jy. et al. Glutathione S-transferase gene polymorphisms and susceptibility to chronic myeloid leukemia. Tumor Biol. 35, 6119–6125 (2014). https://doi.org/10.1007/s13277-014-1810-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-014-1810-7

Keywords

Navigation